HealthCare Global Enterprises Limited (NSE: HCG)
India
· Delayed Price · Currency is INR | Market Cap | 56.28B |
| Revenue (ttm) | 19.77B |
| Net Income (ttm) | 526.10M |
| Shares Out | 139.35M |
| EPS (ttm) | 3.75 |
| PE Ratio | 107.66 |
| Forward PE | 65.15 |
| Dividend | n/a |
| Ex-Dividend Date | n/a |
| Volume | 200,279 |
| Open | 409.55 |
| Previous Close | 409.90 |
| Day's Range | 402.00 - 412.10 |
| 52-Week Range | 314.00 - 415.00 |
| Beta | n/a |
| Analysts | n/a |
| Price Target | n/a |
| Earnings Date | Nov 8, 2024 |
About HCG
HealthCare Global Enterprises Limited, together with its subsidiaries, provides medical and healthcare services focusing on cancer and fertility in India and internationally. The company offers cancer diagnosis and treatment services through radiation therapy, medical oncology, and surgery; and fertility treatment services, including reproductive medicine, assisted reproduction, gynecological endoscopy, and fertility preservation under the Milann brand. It also operates multi-specialty hospitals under the HCG brand that provides inpatient and o... [Read more]
Financial Performance
In 2023, HCG's revenue was 19.12 billion, an increase of 12.85% compared to the previous year's 16.94 billion. Earnings were 481.55 million, an increase of 64.08%.
Financial StatementsNews
Bain Is Said to Be Frontrunner For Indian Hospital Chain HCG
Bain Capital has emerged as the frontrunner to acquire a controlling stake in Indian cancer hospital chain HealthCare Global Enterprises Ltd., according to people familiar with the matter.